Category: Antibody Technologies
Global Antibody Technologies
-
Global Immunosuppressants Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Global Protein A Resin Market 2024-2028
... forecast period. The report on the protein A resin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market 2024-2028
... on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033
... Lung Cancer; Brain Tumor4) By End User: Hospital; Clinics; Specialty CentersCovering: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 ... Read More
-
Ion Channel Modulators
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Cell Surface Markers
... by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$981.1 Million by the ... Read More
-
Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines. The Global Rituxan (Rituximab) Monoclonal Antibody Market Size was estimated at USD 4326.07 million in 2023 ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Monoclonal Antibodies
... at a CAGR of 6.8% over the analysis period 2023-2030. Human-sourced Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$105.2 Billion by the end ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% ... Read More
-
Biosensors
... of 7.1% over the analysis period 2023-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$25.9 Billion by the end of the analysis period. ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications
... during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of conditions, accounting to at least 150 distinct disorders. In Europe, a condition is deemed rare if its prevalence falls below 1 in 2000 ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
Immunochemicals
... of 5.2% over the analysis period 2023-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
2024 Global: Immunoprecipitation Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
Global Injectable Cytotoxic Drugs Market (2024 Edition): Market Size, Trends, Opportunities and Forecast By Drug Class (Plant Alkaloids, Alkylating Drugs, Antimetabolites, Cytotoxic Antibodies and Other Drug Classes), Application, Distribution Channel, Region, By Country: 2020-2030
... A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Injectable Cytotoxic Drugs Market (2024 Edition)”. According to the report, Global Injectable Cytotoxic Drugs Market valued at USD 18.3 Billion ... Read More
-
2024 Global: Immunohistochemistry Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Immunohistochemistry Reagent Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Neuroscience Antibodies And Assays Market - Innovative Markets Forecast (2030) report
... data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 ... Read More
-
2024 Global: Mammalian Polyclonal Igg Antibody Market - Innovative Markets Forecast (2030) report
... data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 ... Read More
-
2024 Global: Monoclonal Antibodies Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Recombinant Proteins Market
... for 2029, the market’s competitive environment and companies’ pipeline activities. The report delivers market estimates and forecasts for recombinant proteins categorized according to product type, host cell type, application, and region. Based on product type ... Read More
-
Global Bispecific Antibodies For Cancer Market 2024-2028
... on the bispecific antibodies for cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More